# Mixed Amphetamine Salts (Adderall)
# Primarily US market; illegal in Japan; limited availability elsewhere

id: "amphetamine-mixed-salts"

brandNames:
  US: ["Adderall", "Adderall XR", "Mydayis"]
  CN: []
  EU: []
  JP: []
  UK: []
  AU: []
  CA: ["Adderall XR"]

genericName:
  en: "mixed amphetamine salts (amphetamine/dextroamphetamine)"
  zh: "混合苯丙胺盐（苯丙胺/右旋苯丙胺）"
  ja: "混合アンフェタミン塩（アンフェタミン/デキストロアンフェタミン）"

manufacturers:
  - name: "Teva Pharmaceuticals"
    region: "US"
    product: "Adderall/Adderall XR"
  - name: "Takeda (formerly Shire)"
    region: "US"
    product: "Mydayis"

# Classification
drugClass: "stimulant"

drugClassLabel:
  en: "Stimulant"
  zh: "兴奋剂"
  ja: "中枢刺激薬"

category: "amphetamine"

categoryLabel:
  en: "Amphetamine"
  zh: "苯丙胺类"
  ja: "アンフェタミン系"
controlledSubstance: true
schedule:
  US: "Schedule II"
  CN: "Illegal/Not approved"
  EU: "Varies; generally not available"
  JP: "Illegal (覚醒剤取締法)"
  UK: "Class B, Schedule 2 (rarely prescribed)"

# Mechanism
activeIngredient:
  en: "mixed amphetamine salts (75% dextroamphetamine, 25% levoamphetamine)"
  zh: "混合苯丙胺盐（75%右旋苯丙胺，25%左旋苯丙胺）"
  ja: "混合アンフェタミン塩（75%デキストロアンフェタミン、25%レボアンフェタミン）"

mechanismOfAction:
  en: "Increases release of dopamine and norepinephrine from nerve terminals; blocks reuptake of these neurotransmitters. The combination of amphetamine salts provides both rapid onset and extended duration."
  zh: "增加神经末梢多巴胺和去甲肾上腺素的释放；阻断这些神经递质的再摄取。混合苯丙胺盐的组合提供快速起效和持久作用。"
  ja: "神経末端からのドーパミンとノルエピネフリンの放出を増加させ、これらの神経伝達物質の再取り込みを阻害します。アンフェタミン塩の組み合わせにより、迅速な効果発現と持続的な作用を提供します。"
neurotransmittersAffected:
  - dopamine
  - norepinephrine
  - trace amounts of serotonin

# Dosage & Forms
forms:
  - type: "tablet"
    typeLabel:
      en: "Tablet"
      zh: "片剂"
      ja: "錠剤"
    releaseType: "immediate"
    releaseTypeLabel:
      en: "Immediate Release"
      zh: "速释"
      ja: "即放性"
    brandName: "Adderall"
    strengths: ["5mg", "7.5mg", "10mg", "12.5mg", "15mg", "20mg", "30mg"]
    durationHours: 4-6
    notes:
      en: "Usually taken 2-3 times daily"
      zh: "通常每日服用2-3次"
      ja: "通常1日2〜3回服用"

  - type: "capsule"
    typeLabel:
      en: "Capsule"
      zh: "胶囊"
      ja: "カプセル"
    releaseType: "extended"
    releaseTypeLabel:
      en: "Extended Release"
      zh: "缓释"
      ja: "徐放性"
    brandName: "Adderall XR"
    strengths: ["5mg", "10mg", "15mg", "20mg", "25mg", "30mg"]
    durationHours: 10-12
    notes:
      en: "Once daily; can be opened and sprinkled on food"
      zh: "每日一次；可打开撒在食物上"
      ja: "1日1回；カプセルを開けて食べ物にふりかけることができます"

  - type: "capsule"
    typeLabel:
      en: "Capsule"
      zh: "胶囊"
      ja: "カプセル"
    releaseType: "extended"
    releaseTypeLabel:
      en: "Extended Release"
      zh: "缓释"
      ja: "徐放性"
    brandName: "Mydayis"
    strengths: ["12.5mg", "25mg", "37.5mg", "50mg"]
    durationHours: 16
    notes:
      en: "Triple-bead formulation for 16-hour coverage"
      zh: "三层微珠制剂，提供16小时覆盖"
      ja: "16時間カバーのためのトリプルビーズ製剤"

# Efficacy
onsetMinutes: 30-60
peakEffectHours: 3
durationHours: 4-6  # IR; 10-16 for XR

# Side Effects
sideEffects:
  common:
    - name:
        en: "decreased appetite"
        zh: "食欲下降"
        ja: "食欲減退"
      frequency: "25-35%"
    - name:
        en: "insomnia"
        zh: "失眠"
        ja: "不眠"
      frequency: "20-30%"
    - name:
        en: "dry mouth"
        zh: "口干"
        ja: "口渇"
      frequency: "15-25%"
    - name:
        en: "weight loss"
        zh: "体重减轻"
        ja: "体重減少"
      frequency: "10-20%"
    - name:
        en: "headache"
        zh: "头痛"
        ja: "頭痛"
      frequency: "10-15%"
    - name:
        en: "stomach pain"
        zh: "胃痛"
        ja: "胃痛"
      frequency: "10-15%"
    - name:
        en: "anxiety/nervousness"
        zh: "焦虑/紧张"
        ja: "不安/緊張"
      frequency: "10%"

  uncommon:
    - name:
        en: "tachycardia"
        zh: "心动过速"
        ja: "頻脈"
      frequency: "5-10%"
    - name:
        en: "mood swings"
        zh: "情绪波动"
        ja: "気分変動"
      frequency: "5-10%"
    - name:
        en: "dizziness"
        zh: "头晕"
        ja: "めまい"
      frequency: "5%"
    - name:
        en: "restlessness"
        zh: "烦躁不安"
        ja: "落ち着きのなさ"
      frequency: "5%"

  serious:
    - name:
        en: "cardiovascular events"
        zh: "心血管事件"
        ja: "心血管イベント"
      notes:
        en: "Sudden death, stroke, myocardial infarction reported"
        zh: "有猝死、中风、心肌梗死报告"
        ja: "突然死、脳卒中、心筋梗塞の報告あり"
    - name:
        en: "psychiatric symptoms"
        zh: "精神症状"
        ja: "精神症状"
      notes:
        en: "New or worsening psychosis, mania, aggression"
        zh: "新发或加重的精神病、躁狂、攻击性"
        ja: "新規または悪化する精神病、躁病、攻撃性"
    - name:
        en: "seizures"
        zh: "癫痫发作"
        ja: "発作"
      notes:
        en: "May lower seizure threshold"
        zh: "可能降低癫痫阈值"
        ja: "発作閾値を下げる可能性"
    - name:
        en: "peripheral vasculopathy"
        zh: "外周血管病变"
        ja: "末梢血管障害"
      notes:
        en: "Raynaud's phenomenon"
        zh: "雷诺现象"
        ja: "レイノー現象"
    - name:
        en: "serotonin syndrome"
        zh: "血清素综合征"
        ja: "セロトニン症候群"
      notes:
        en: "With concurrent serotonergic drugs"
        zh: "与血清素能药物联用时"
        ja: "セロトニン作動薬との併用時"

# Safety
contraindications:
  en:
    - "Hypersensitivity to amphetamines"
    - "MAO inhibitor use within 14 days"
    - "Advanced arteriosclerosis"
    - "Symptomatic cardiovascular disease"
    - "Moderate to severe hypertension"
    - "Hyperthyroidism"
    - "Glaucoma"
    - "Agitated states"
    - "History of drug abuse"
  zh:
    - "对苯丙胺类过敏"
    - "14天内使用过MAO抑制剂"
    - "晚期动脉硬化"
    - "有症状的心血管疾病"
    - "中度至重度高血压"
    - "甲状腺功能亢进"
    - "青光眼"
    - "激动状态"
    - "药物滥用史"
  ja:
    - "アンフェタミン類に対する過敏症"
    - "14日以内のMAO阻害剤使用"
    - "進行性動脈硬化"
    - "症候性心血管疾患"
    - "中等度から重度の高血圧"
    - "甲状腺機能亢進症"
    - "緑内障"
    - "興奮状態"
    - "薬物乱用歴"

drugInteractions:
  - drug:
      en: "MAO inhibitors"
      zh: "MAO抑制剂"
      ja: "MAO阻害剤"
    severity: "major"
    effect:
      en: "Hypertensive crisis"
      zh: "高血压危象"
      ja: "高血圧クリーゼ"
  - drug:
      en: "Serotonergic drugs"
      zh: "血清素能药物"
      ja: "セロトニン作動薬"
    severity: "major"
    effect:
      en: "Serotonin syndrome risk"
      zh: "血清素综合征风险"
      ja: "セロトニン症候群のリスク"
  - drug:
      en: "Acidifying agents (vitamin C)"
      zh: "酸化剂（维生素C）"
      ja: "酸性化剤（ビタミンC）"
    severity: "moderate"
    effect:
      en: "Decrease amphetamine levels"
      zh: "降低苯丙胺血药浓度"
      ja: "アンフェタミン濃度の低下"
  - drug:
      en: "Alkalinizing agents"
      zh: "碱化剂"
      ja: "アルカリ化剤"
    severity: "moderate"
    effect:
      en: "Increase amphetamine levels"
      zh: "增加苯丙胺血药浓度"
      ja: "アンフェタミン濃度の上昇"
  - drug:
      en: "Tricyclic antidepressants"
      zh: "三环类抗抑郁药"
      ja: "三環系抗うつ薬"
    severity: "moderate"
    effect:
      en: "Enhanced TCA effects"
      zh: "三环类抗抑郁药作用增强"
      ja: "TCA作用の増強"

blackBoxWarnings:
  en:
    - "High potential for abuse and dependence"
    - "Sudden death and serious cardiovascular adverse events"
  zh:
    - "高度滥用和依赖风险"
    - "猝死和严重心血管不良事件"
  ja:
    - "乱用および依存の可能性が高い"
    - "突然死および重篤な心血管有害事象"

pregnancyCategory: "C"

foodInteractions:
  en: "Avoid vitamin C, citrus, acidic foods within 1 hour of dosing (reduces absorption)"
  zh: "服药前后1小时内避免维生素C、柑橘类、酸性食物（降低吸收）"
  ja: "服用前後1時間以内はビタミンC、柑橘類、酸性食品を避ける（吸収低下）"

# Practical Information
typicalDosing:
  children:
    startingDose: "5mg once or twice daily (IR) or 10mg once daily (XR)"
    maxDose: "30mg/day (children 6-12) or 40mg/day (adolescents)"
    notes:
      en: "Start low, increase by 5-10mg weekly"
      zh: "从低剂量开始，每周增加5-10mg"
      ja: "低用量から開始し、毎週5〜10mg増量"
  adults:
    startingDose: "5-10mg twice daily (IR) or 20mg once daily (XR)"
    maxDose: "40mg/day (IR) or 60mg/day (XR)"
    notes:
      en: "Higher doses may be needed for adults"
      zh: "成人可能需要更高剂量"
      ja: "成人は高用量が必要な場合がある"

costEstimate:
  US:
    brand: "$350-450/month"
    generic: "$30-80/month"
  CN:
    brand: "Not available"
    generic: "Not available"

storageRequirements:
  en: "Room temperature (20-25°C), protect from light and moisture"
  zh: "室温保存（20-25°C），避光避湿"
  ja: "室温（20-25°C）で保存、光と湿気を避ける"

# Approval & Availability
approvals:
  - region: "US"
    agency: "FDA"
    year: 1996
    approvedAges:
      en: "3 years and older (IR); 6 years and older (XR)"
      zh: "3岁及以上（速释）；6岁及以上（缓释）"
      ja: "3歳以上（IR）；6歳以上（XR）"
    indications:
      en: ["ADHD", "Narcolepsy (IR only)"]
      zh: ["注意缺陷多动障碍", "发作性睡病（仅速释）"]
      ja: ["ADHD", "ナルコレプシー（IRのみ）"]
    available: true
    notes:
      en: "Adderall XR approved 2001; Mydayis approved 2017"
      zh: "Adderall XR于2001年获批；Mydayis于2017年获批"
      ja: "Adderall XRは2001年承認；Mydayisは2017年承認"

  - region: "CN"
    agency: "NMPA"
    year: null
    approvedAges:
      en: ""
      zh: ""
      ja: ""
    indications:
      en: []
      zh: []
      ja: []
    available: false
    notes:
      en: "Not approved; amphetamines are controlled substances"
      zh: "未批准；苯丙胺类为管制物质"
      ja: "未承認；アンフェタミン類は規制物質"

  - region: "EU"
    agency: "EMA"
    year: null
    approvedAges:
      en: ""
      zh: ""
      ja: ""
    indications:
      en: []
      zh: []
      ja: []
    available: false
    notes:
      en: "Not approved in most EU countries; some exceptions"
      zh: "大多数欧盟国家未批准；少数例外"
      ja: "ほとんどのEU諸国で未承認；一部例外あり"

  - region: "JP"
    agency: "PMDA"
    year: null
    approvedAges:
      en: ""
      zh: ""
      ja: ""
    indications:
      en: []
      zh: []
      ja: []
    available: false
    notes:
      en: "Illegal in Japan under Stimulants Control Act (覚醒剤取締法)"
      zh: "在日本根据《兴奋剂取缔法》（覚醒剤取締法）为非法"
      ja: "覚醒剤取締法により日本では違法"

  - region: "UK"
    agency: "MHRA"
    year: null
    approvedAges:
      en: ""
      zh: ""
      ja: ""
    indications:
      en: []
      zh: []
      ja: []
    available: false
    notes:
      en: "Rarely prescribed; dexamphetamine preferred"
      zh: "很少处方；首选右旋苯丙胺"
      ja: "処方されることは稀；デキストロアンフェタミンが優先"

  - region: "CA"
    agency: "Health Canada"
    year: 2004
    approvedAges:
      en: "6 years and older"
      zh: "6岁及以上"
      ja: "6歳以上"
    indications:
      en: ["ADHD"]
      zh: ["注意缺陷多动障碍"]
      ja: ["ADHD"]
    available: true
    notes:
      en: "Adderall XR only; IR not available"
      zh: "仅有Adderall XR；速释制剂不可用"
      ja: "Adderall XRのみ；IRは利用不可"

# Special Considerations
specialConsiderations:
  cardiacRisk:
    en: "Higher cardiovascular risk than some alternatives; screen before starting"
    zh: "心血管风险高于部分替代药物；开始前需筛查"
    ja: "一部の代替薬より心血管リスクが高い；開始前にスクリーニングが必要"
  abuseRisk:
    en: "High abuse potential; one of the most commonly misused ADHD medications"
    zh: "高滥用风险；是最常被滥用的ADHD药物之一"
    ja: "乱用の可能性が高い；最も一般的に乱用されるADHD薬の一つ"
  withdrawalNotes:
    en: "Crash, fatigue, depression on discontinuation; no severe physical withdrawal"
    zh: "停药时出现崩溃感、疲劳、抑郁；无严重身体戒断症状"
    ja: "中止時にクラッシュ、疲労、うつが発生；重度の身体的離脱症状はない"
  monitoringRequired:
    en: "Height, weight, blood pressure, heart rate, psychiatric symptoms"
    zh: "身高、体重、血压、心率、精神症状"
    ja: "身長、体重、血圧、心拍数、精神症状"

# Travel Rules
travelRules:
  generalAdvice:
    en: "Mixed amphetamine salts face severe restrictions internationally. This medication is ILLEGAL in many countries including Japan. Always verify regulations before travel."
    zh: "混合苯丙胺盐在国际上面临严格限制。此药物在日本等许多国家是非法的。旅行前务必核实相关规定。"
    ja: "混合アンフェタミン塩は国際的に厳しい制限があります。この薬は日本を含む多くの国で違法です。旅行前に必ず規制を確認してください。"

  requiredDocumentation:
    - type: "prescription"
      typeLabel:
        en: "Valid prescription"
        zh: "有效处方"
        ja: "有効な処方箋"
      notes:
        en: "Original prescription in original packaging"
        zh: "原始处方和原包装"
        ja: "元の処方箋と元のパッケージ"
    - type: "medical_letter"
      typeLabel:
        en: "Doctor's letter"
        zh: "医生证明信"
        ja: "医師の診断書"
      notes:
        en: "Detailed letter explaining medical necessity"
        zh: "详细说明医疗必要性的证明信"
        ja: "医学的必要性を説明する詳細な手紙"

  maxPersonalSupply:
    default: "90 days"
    byRegion:
      CA: "90 days"

  crossBorderRules:
    - fromRegion: "US"
      toRegion: "JP"
      status: "prohibited"
      statusLabel:
        en: "Prohibited - Illegal"
        zh: "禁止 - 非法"
        ja: "禁止 - 違法"
      requirements:
        en: []
        zh: []
        ja: []
      notes:
        en: "Mixed amphetamine salts are ILLEGAL in Japan under the Stimulants Control Act (覚醒剤取締法). Do NOT bring this medication to Japan under ANY circumstances. You may face arrest and imprisonment."
        zh: "混合苯丙胺盐根据日本《兴奋剂取缔法》（覚醒剤取締法）是非法的。任何情况下都不要将此药物带入日本。您可能面临逮捕和监禁。"
        ja: "混合アンフェタミン塩は覚醒剤取締法により日本では違法です。いかなる状況下でもこの薬を日本に持ち込まないでください。逮捕・投獄される可能性があります。"
      sources:
        - "https://www.ncd.mhlw.go.jp/en/application.html"

    - fromRegion: "US"
      toRegion: "CN"
      status: "prohibited"
      statusLabel:
        en: "Prohibited"
        zh: "禁止"
        ja: "禁止"
      requirements:
        en: []
        zh: []
        ja: []
      notes:
        en: "Amphetamines are strictly illegal in China. Severe legal penalties including long prison sentences apply."
        zh: "苯丙胺类药物在中国严格违禁。将面临包括长期监禁在内的严厉法律处罚。"
        ja: "アンフェタミン類は中国で厳格に違法です。長期の懲役刑を含む厳しい法的処罰が科されます。"
      sources:
        - "https://www.china-embassy.org/eng/"

    - fromRegion: "US"
      toRegion: "EU"
      status: "prohibited"
      statusLabel:
        en: "Generally Not Allowed"
        zh: "一般不允许"
        ja: "通常許可されない"
      requirements:
        en: []
        zh: []
        ja: []
      notes:
        en: "Mixed amphetamine salts are not approved in most EU countries. Even with a prescription, import is typically not permitted. Consider switching to methylphenidate before travel."
        zh: "混合苯丙胺盐在大多数欧盟国家未获批准。即使有处方，进口通常也不被允许。考虑在旅行前换用哌甲酯。"
        ja: "混合アンフェタミン塩はほとんどのEU諸国で承認されていません。処方箋があっても、通常輸入は許可されません。旅行前にメチルフェニデートへの切り替えを検討してください。"
      sources:
        - "https://www.emcdda.europa.eu/"

    - fromRegion: "US"
      toRegion: "UK"
      status: "restricted"
      statusLabel:
        en: "Restricted - Rarely Permitted"
        zh: "受限 - 很少允许"
        ja: "制限あり - 許可されることは稀"
      requirements:
        en:
          - "Contact UK Home Office before travel"
          - "May need special import license"
        zh:
          - "旅行前联系英国内政部"
          - "可能需要特殊进口许可证"
        ja:
          - "旅行前に英国内務省に連絡"
          - "特別な輸入許可が必要な場合あり"
      maxSupply: "3 months"
      notes:
        en: "Mixed amphetamine salts are rarely prescribed in UK. Import may be complicated. Consider asking your doctor about alternatives available in UK."
        zh: "混合苯丙胺盐在英国很少处方。进口可能很复杂。考虑向医生咨询英国可用的替代药物。"
        ja: "混合アンフェタミン塩は英国でほとんど処方されません。輸入は複雑な場合があります。英国で利用可能な代替薬について医師に相談してください。"
      sources:
        - "https://www.gov.uk/travelling-controlled-drugs"

    - fromRegion: "US"
      toRegion: "AU"
      status: "restricted"
      statusLabel:
        en: "Restricted - Special Permission Needed"
        zh: "受限 - 需要特别许可"
        ja: "制限あり - 特別許可が必要"
      requirements:
        en:
          - "Apply to TGA for import permit"
          - "Declare at customs"
          - "Carry prescription and doctor's letter"
        zh:
          - "向TGA申请进口许可"
          - "在海关申报"
          - "携带处方和医生证明信"
        ja:
          - "TGAに輸入許可を申請"
          - "税関で申告"
          - "処方箋と医師の手紙を携帯"
      maxSupply: "3 months"
      notes:
        en: "Australia may allow import with proper documentation but verify with TGA before travel."
        zh: "澳大利亚可能允许携带适当文件入境，但旅行前请向TGA核实。"
        ja: "オーストラリアは適切な書類があれば輸入を許可する場合がありますが、旅行前にTGAに確認してください。"
      sources:
        - "https://www.tga.gov.au/entering-australia"

    - fromRegion: "US"
      toRegion: "CA"
      status: "allowed"
      statusLabel:
        en: "Allowed with Prescription"
        zh: "凭处方允许"
        ja: "処方箋があれば許可"
      requirements:
        en:
          - "Carry medication in original labeled container"
          - "Bring copy of prescription"
          - "Quantity for personal use only"
        zh:
          - "携带原标签容器中的药物"
          - "携带处方副本"
          - "仅限个人使用量"
        ja:
          - "元のラベル付き容器で薬を携帯"
          - "処方箋のコピーを持参"
          - "個人使用分のみ"
      maxSupply: "90 days"
      notes:
        en: "Canada-US border crossing is straightforward for personal use quantities with proper documentation."
        zh: "携带适当文件过加美边境，个人使用量较为简单。"
        ja: "適切な書類があれば、個人使用量でのカナダ-米国国境通過は簡単です。"
      sources:
        - "https://www.cbsa-asfc.gc.ca/"

# Metadata
lastUpdated: 2025-12-02

sources:
  - "https://www.additudemag.com/adhd-medications-list-chart-stimulants-nonstimulants/"
  - "https://interacnetwork.com/navigating-stimulant-therapy-for-adult-adhd-in-japan-regulations-and-considerations/"
  - "https://www.fda.gov/consumers/consumer-updates/treating-and-dealing-adhd"

notes:
  en: "Primarily a US medication. Illegal in Japan. Not available in most of Europe. Often associated with college student misuse. Significant supply shortages in US during 2022-2023."
  zh: "主要是美国药物。在日本为非法。欧洲大部分地区不可用。常与大学生滥用相关。2022-2023年美国出现严重供应短缺。"
  ja: "主に米国の薬。日本では違法。ヨーロッパのほとんどの地域で利用不可。大学生の乱用と関連することが多い。2022-2023年に米国で深刻な供給不足が発生。"
